These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11794403)

  • 1. Genetic sonography: a cost-effective method for evaluating women 35 years and older who decline genetic amniocentesis.
    DeVore GR; Romero R
    J Ultrasound Med; 2002 Jan; 21(1):5-13. PubMed ID: 11794403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is genetic ultrasound cost-effective?
    DeVore GR
    Semin Perinatol; 2003 Apr; 27(2):173-82. PubMed ID: 12769203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic sonography: an option for women of advanced maternal age with negative triple-marker maternal serum screening results.
    DeVore GR; Romero R
    J Ultrasound Med; 2003 Nov; 22(11):1191-9. PubMed ID: 14620890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of genetic sonography and maternal serum triple-marker screening: an effective method for increasing the detection of trisomy 21 in women younger than 35 years.
    DeVore GR; Romero R
    J Ultrasound Med; 2001 Jun; 20(6):645-54. PubMed ID: 11400939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
    Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
    J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial.
    Malan V; Bussières L; Winer N; Jais JP; Baptiste A; Le Lorc'h M; Elie C; O'Gorman N; Fries N; Houfflin-Debarge V; Sentilhes L; Vekemans M; Ville Y; Salomon LJ;
    JAMA; 2018 Aug; 320(6):557-565. PubMed ID: 30120476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of color Doppler ultrasound to identify fetuses at increased risk for trisomy 21: an alternative for high-risk patients who decline genetic amniocentesis.
    DeVore GR; Alfi O
    Obstet Gynecol; 1995 Mar; 85(3):378-86. PubMed ID: 7862376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
    Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
    Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indication-specific accuracy of second-trimester genetic ultrasonography for the detection of trisomy 21.
    Vintzileos AM; Guzman ER; Smulian JC; Day-Salvatore DL; Knuppel RA
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1045-8. PubMed ID: 10561615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic evaluation of second-trimester genetic ultrasonography for prenatal detection of down syndrome.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
    Am J Obstet Gynecol; 1998 Nov; 179(5):1214-9. PubMed ID: 9822503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
    Sullivan A; Giudice T; Vavelidis F; Thiagarajah S
    Am J Obstet Gynecol; 1999 Aug; 181(2):260-5. PubMed ID: 10454666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic evaluation of first-trimester genetic sonography for prenatal detection of Down syndrome.
    Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T
    Obstet Gynecol; 1998 Apr; 91(4):535-9. PubMed ID: 9540936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice.
    Bornstein E; Lenchner E; Donnenfeld A; Barnhard Y; Seubert D; Divon MY
    J Perinat Med; 2009; 37(2):99-102. PubMed ID: 18999912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal midtrimester (17-20 weeks) genetic sonogram decreases amniocentesis rate in a high-risk population.
    Pinette MG; Garrett J; Salvo A; Blackstone J; Pinette SG; Boutin N; Cartin A
    J Ultrasound Med; 2001 Jun; 20(6):639-44. PubMed ID: 11400938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of genetic sonography to reduce the need for amniocentesis in women at high-risk for Down syndrome.
    Yeo L; Vintzileos AM
    Semin Perinatol; 2003 Apr; 27(2):152-9. PubMed ID: 12769201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-trimester genetic sonography after first-trimester combined screening for trisomy 21.
    Wax JR; Pinette MG; Cartin A; Blackstone J
    J Ultrasound Med; 2009 Mar; 28(3):321-5. PubMed ID: 19244068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.